Yahoo Web Search

Search results

1. • Geneoscopy Nabs FDA Approval for Stool-Based Colorectal Cancer Screening Test

     GenomeWeb News· 1 week ago

     Oncology diagnostics firm Geneoscopy said Tuesday that the US Food and Drug Administration has approved its noninvasive, stool-based colorectal cancer screening ...

2. • New Day Diagnostics Aims to Enter CRC Screening Market With Combined PCR, Immunoassay Test

     GenomeWeb News· 2 weeks ago

     With technologies brought under one roof through a pair of deals last summer, New Day Diagnostics aims to complete within the next two years the development of a blood-based screening

3. • 

     Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight

     GuruFocus.com via Yahoo Finance· 1 week ago

     The company's flagship product, Cologuard, is the first FDA-approved non-invasive stool-based DNA...

4. • 

     Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024

     InvestorPlace· 15 hours ago

     The ARK Innovation ETF (NYSEARCA:ARKK) has come under the spotlight recently, and there are three...

5. • 

     Exact Sciences blood test for many cancers is going to patients this summer

     Wisconsin State Journal· 5 days ago

     Exact Sciences’ new push, a blood test for many types of cancer at once, will become available to...

6. • New test going to patients in study

     Wisconsin State Journal· 5 days ago

     Exact Sciences' new push, a blood test for many types of cancer at once, will become available to some patients this summer, as the Madison company seeks Medicare coverage ...

7. • Analysts Set Exact Sciences Co. (NASDAQ:EXAS) PT at $97.44

     ETF DAILY NEWS· 1 week ago

     Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) has received a consensus rating of “Moderate Buy” from the thirteen ratings firms that are presently covering the stock, MarketBeat.com reports ...

8. • Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Teacher Retirement System of Texas

     ETF DAILY NEWS· 3 days ago

     Teacher Retirement System of Texas lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 11.5% during the fourth quarter, according to the company in its most ...

9. • Natixis Advisors L.P. Sells 2,370 Shares of Exact Sciences Co. (NASDAQ:EXAS)

     ETF DAILY NEWS· 7 days ago

     Natixis Advisors L.P. trimmed its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange ...